Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs
Abstract Recently, research has focused on targeting the oxidative and metabolic vulnerabilities in cancer cells. Natural compounds like curcumin that target such susceptibilities have failed further clinical advancements due to the poor stability and bioavailability as well as the need of high effe...
Main Authors: | Christopher Pignanelli, Dennis Ma, Megan Noel, Jesse Ropat, Fadi Mansour, Colin Curran, Simon Pupulin, Kristen Larocque, Jianzhang Wu, Guang Liang, Yi Wang, Siyaram Pandey |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-01230-4 |
Similar Items
-
Evaluating the Anti-cancer Efficacy of a Synthetic Curcumin Analog on Human Melanoma Cells and Its Interaction with Standard Chemotherapeutics
by: Krishan Parashar, et al.
Published: (2019-07-01) -
Anti-Lung Cancer Activity of the Curcumin Analog JZ534 In Vitro
by: Jianzhang Wu, et al.
Published: (2015-01-01) -
Exploiting Mitochondrial Vulnerabilities to Trigger Apoptosis Selectively in Cancer Cells
by: Christopher Nguyen, et al.
Published: (2019-06-01) -
Synthesis and Evaluation of a Series of Novel Asymmetrical Curcumin Analogs for the Treatment of Inflammation
by: Yali Zhang, et al.
Published: (2014-06-01) -
Xanthine Oxidase and α-Glucosidase Inhibition of Curcumin and Curcumin Analogs
by: Chen Chu Ze, et al.
Published: (2015)